C1 inhibitor — Drug Target
All drugs that target C1 inhibitor — marketed and clinical-stage. Includes 2 drug classes acting on this target.
Drug classes
Complement system regulator · Complement inhibitor
Phase 3 pipeline (1)
- recombinant human C1 inhibitor · Pharming Technologies B.V. · Complement system regulator · Immunology
Recombinant human C1 inhibitor works by replacing a deficient or dysfunctional C1 inhibitor protein to regulate the complement system and prevent excessive inflammation.
Phase 2 pipeline (1)
- BCX4161 · BioCryst Pharmaceuticals · Complement inhibitor · Immunology
BCX4161 is a small molecule inhibitor of the C1 inhibitor of the complement system.